News 4: Bamlanivimab not easy to pronounce, but provides Texas hospitals new COVID treatment
November 23, 2020
The first shipments of an experimental antibody therapy for COVID-19 have arrived in Texas. It’s not easy to pronounce, but bamlanivimab has been shown to prevent high-risk patients from ending up in the hospital. Watch the full story at News 4